Variant Nitrile Hydratase Mutations for Stable Acrylamide Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nitrile hydratase biocatalysts used for converting nitriles to amides face challenges with stability and activity, as they are deactivated by acrylonitrile and acrylamide, and modified biocatalysts often lack rapid conversion rates.

Innovation Solution

Engineering a novel nitrile hydratase with specific mutations in its alpha and beta subunits, optimized for enhanced stability and activity, and integrating it into suitable microorganisms for improved biocatalytic performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If nitrile hydratase biocatalysts are used for converting nitriles to amides, then the conversion reaction can proceed under milder conditions compared to chemical synthesis, but the biocatalysts are deactivated by acrylonitrile and acrylamide, reducing stability

Engineering Contradiction:
Improvereaction condition mildnessVSAvoidbiocatalyst stability
Core Design Contradiction:
TemperatureVSReliability

Solution Approach 1:

The patent applies parameter changes by introducing specific amino acid mutations (L6T, A19V, F126Y in alpha subunit; E108D, A200E in beta subunit) to modify the biocatalyst's physical and chemical properties. These mutations change the enzyme's structure to enhance its resistance to deactivation by acrylonitrile and acrylamide, thereby improving stability while maintaining the mild reaction conditions

Inventive Principle:
Principle #35Parameter changes

2Reliability

If nitrile hydratase biocatalysts are modified to enhance stability, then resistance to deactivation by acrylonitrile and acrylamide is improved, but the activity and rapid conversion rate are reduced

Engineering Contradiction:
Improvebiocatalyst stabilityVSAvoidconversion rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses parameter changes by introducing specific amino acid mutations that simultaneously improve both stability and activity. The mutations L6T, A19V, F126Y in the alpha subunit and E108D, A200E in the beta subunit are designed to enhance resistance to deactivation while maintaining or improving catalytic activity, resolving the trade-off between stability and productivity

Inventive Principle:
Principle #35Parameter changes

3Productivity

If unmodified nitrile hydratase biocatalysts are used, then high activity and rapid conversion of acrylonitrile to acrylamide is achieved, but the biocatalysts lack stability and are quickly deactivated

Engineering Contradiction:
Improveconversion rateVSAvoidbiocatalyst stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by introducing specific amino acid mutations (L6T, A19V, F126Y in alpha subunit; E108D, A200E in beta subunit) that modify the enzyme's structure to enhance its resistance to deactivation. These changes allow the biocatalyst to maintain high conversion rates while significantly improving stability compared to unmodified biocatalysts

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified nitrile hydratase exhibits increased stability and rapid conversion of acrylonitrile to acrylamide, suitable for industrial production with high yield and stability under reaction conditions.

Implementation Method 1

nitrile hydratase, a microbial enzyme that hydrolyses nitriles to amides

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

nitrile hydratase producing microorganisms as biocatalysts

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS20250297293A1Variant nitrile hydratases, microbia which express same, and use in amide synthesis
Publication Date: 2025.09.25 KEMIRA OY
  • US20250297293A1 patent drawing
  • US20250297293A1 patent drawing
  • US20250297293A1 patent drawing

AI summary

The present invention relates to a variant nitrile hydratase which is engineered to comprise greater activity and/or stability, nucleic acids encoding said nitrile hydratase, and microbia engineered to express said novel nitrile hydratase. Additionally the invention relates to the use of this nitrile hydratase and microbia which express said nitrile hydratase as a biocatalyst, particularly in methods for producing an amide compound from a nitrile compound, preferably for use in converting acrylonitrile to acrylamide.